38 Targeted genome editing using engineered nucleases facilitates the creation of bona 39 fide cellular models for biological research and may be applied to human cell-based 40 therapies. Broadly applicable and versatile methods for increasing the levels of gene 41 editing in cell populations remain highly desirable due to the variable efficiency 42 between distinct genomic loci and cell types. Harnessing the multiplexing 43 capabilities of CRISPR-Cas9 and Cpf1 systems, we designed a simple and robust co-44 selection strategy for enriching cells harboring either nuclease-driven non-45 homologous end joining (NHEJ) or homology-directed repair (HDR) events. 46 Selection for dominant alleles of the endogenous sodium-potassium pump (Na + ,K + -47 ATPase) that render cells resistant to ouabain is used to enrich for custom 48 modifications at another unlinked locus of interest, effectively increasing the 49 recovery of engineered cells. The process was readily adaptable to transformed and 50 primary cells, including hematopoietic stem and progenitor cells (HSPCs). The use 51 of universal CRISPR reagents and a commercially available small molecule 52 inhibitor streamlines the incorporation of marker-free genetic changes in human 53 cells. 54 55 56 57 58 59 60
INTRODUCTION 61
Designer nucleases such as zinc-finger nucleases (ZFNs), TAL effector nucleases 62 (TALENs), and CRISPR systems greatly simplify the generation of cell lines with 63 tailored modifications enabling the study of endogenous genetic elements in human cells 64 in an unparalleled manner 1-3 . In particular, CRISPR-based technologies enable 65 researchers to introduce double-strand breaks (DSBs) to virtually any DNA sequences 66 using sequence-specific guide RNAs that target Cas9 and Cpf1 nucleases to cleave the 67 matching sequence. The ensuing DSBs activate two competing repair pathways, namely 68 NHEJ and HDR to facilitate the precise modification of the targeted endogenous locus. 69 NHEJ repairs the lesion by directly rejoining the two DSB ends without the need for a 70 repair template resulting in either precise religation or formation of small insertion or 71 deletion mutations (indels) at the break site. In contrast, definite sequence changes can be 72 introduced when the HDR machinery uses an exogenous DNA template with sequence 73 homology to the DSB site to repair the lesion (reviewed in 4 ). 74 75 While reprograming the CRISPR apparatus requires trivial molecular biology skills, 76 the cellular activity of different guide RNAs can vary considerably, even when targeting 77 adjacent sequences. Computational guide RNA selection is complex and further 78 optimization is required before accurate prediction of the optimal sequences can be 79 achieved, a limitation that is exacerbated when the target site is restricted to a narrow 80 genomic region 5, 6 . Furthermore, the efficiency of delivery and expression of CRISPR 81 components and donor templates can be highly variable between cells of different origin, 82 greatly affecting overall efficacy. Cell type, cell state, and cell cycle stage also play a 83 major role in determining the efficiency of genome editing as human cells dictate repair 84 outcome and have a propensity to favor NHEJ over HDR. Thus, identifying active guide 85
RNAs, screening and isolating clones with the desired genetic modification can be time 86 consuming and costly. In addition, achieving high levels of gene editing is required for 87 accurate phenotypic analysis when studying bulk populations of cells. 88
89
At its most basic level, higher genome editing frequencies are associated with 90 higher nuclease levels and activity. Consequently, several approaches have been 91 implemented to capture and isolate these subpopulations of cells in order to expedite the 92 generation of isogenic knockout and knock-in clones. First, co-transfection of fluorescent 93 proteins combined with fluorescence-activated cell sorting (FACS) can be used to isolate 94 nuclease-expressing cells 7 . Second, direct coupling of expression of fluorescent proteins 95 and nucleases via 2A peptide sequences allows for efficient isolation of cell populations 96 with increasingly higher nuclease expression levels, which translates into increasingly 97 higher genome editing rates 8 . Fluorescence-based surrogate target gene reporters have 98 also been successfully used to enrich for cells with high nuclease activity 9, 10 . A limitation 99 of these methods is that single-cell FACS enrichment is not suitable for more sensitive 100 cell lines. In addition, multi-DSBs arising from cleavage of the episomal reporter 101 plasmids are likely to induce a gene-independent antiproliferative response as recently 102 described for CRISPR-Cas9-induced DNA breaks 11 . Finally, enhancing HDR-mediated 103 processes by altering cell cycle parameters, the timing of nuclease expression, chemical 104 inhibition of NHEJ and use of HDR agonists show promising results but their general 105 applicability and absence of negative effects on specificity and genome integrity need to 106 be thoroughly evaluated [12] [13] [14] [15] [16] [17] . 107 108 Conceptually distinct and elegant genetic approaches based on the creation of 109 "classical" gain-of-function alleles have been developed in the worm Caenorhabditis 110 elegans. Termed "co-conversion"/ "co-CRISPR", these methods increase markedly the 111 odds of detecting a phenotypically silent targeted mutation through the simultaneous "co-112 conversion" of a mutation in an unrelated target that causes a visible phenotype 18, 19 . It 113 was found that simultaneous introduction of sgRNAs to two different endogenous loci 114 results in double editing events that are not statistically independent. For both NHEJ and 115 HDR-driven modifications, the occurrence of a cleavage and repair event in one locus 116 enhances the probability of finding a heritable mutagenetic event in a second locus in the 117 same animal. A related approach has been described to isolate human cells harboring 118 NHEJ-driven mutations by co-targeting the X-linked hypoxanthine phosphoribosyl-119 transferase (HPRT1) gene 20 . Although relatively efficient, this technique uses a 120 mutagenic chemotherapy drug, does not select for HDR-based events, and may affect the 121 salvage pathway of purines from degraded DNA. Hereditary HPRT1 deficiency is also 122 the cause of Lesch-Nyhan syndrome. More recently, it was found that, in mouse 123 embryonic stem cells, the CRISPR-Cas9-mediated insertion of a drug-selectable marker 124 at one control site frequently coincided with an insertion at an unlinked, and 125 independently targeted site 21 . Still, the insertion of a heterologous selection cassette into 126 the genome of the edited cells may limit applications of this technique. Hence, further 127 refinement of these approaches is needed. 128 gradients of Na + and K + across the plasma membrane of animal cells. It is an essential and 134 ubiquitously expressed enzyme functioning as a heteromeric complex consisting of a 135 large α-subunit (ATP1A1), which is responsible for ATP hydrolysis and ion transport and 136 a β-subunit, acting as a chaperone 22, 23 . Cardiotonic steroids (CTSs), such as ouabain 137 (PubChem CID: 439501), constitute a broad class of specific Na + ,K + -ATPase inhibitors 138 prescribed for congestive heart failure for more than 2 centuries 23 . Many mutagenesis and 139 modeling studies have been carried out on the structure-activity relationships of ouabain 140 clearly defining its mechanism of action and leading to the identification of inhibitor-141 resistant enzymes 22-25 . Using CRISPR-Cas9 and CRISPR-Cpf1, we generated gain-of-142 function alleles in ATP1A1 via either the NHEJ or the HDR DNA repair pathways that 143 were used to co-select, through resistance to ouabain, for mechanistically related editing 144 events at a second locus of interest. This strategy was portable to many guide RNAs, 145 independent of cell type, and is a general solution for facilitating the isolation of genome-146 edited human cells. CTSs have revealed that the inhibitors are wedged very deeply between transmembrane 156 helices in addition to contacting the extracellular surface 22, 23 . Accordingly, random 157 mutagenesis and overexpression studies have pinpointed residues affecting ouabain 158 sensitivity that are localized throughout the protein with clusters of residues conferring 159 the greatest resistance occurring at the H1-H2 transmembrane and extracellular regions 24 . 160
Most prominently, replacement of the border residues (Q118 and N129) of the first 161 extracellular loop with charged amino acids generates highly resistant enzymes when 162 overexpressed in cells 25 (Fig. 1a) . However, it is unknown if deletions in this regions can 163 disrupt ouabain binding while preserving the functionality of ATP1A1. Furthermore, it 164 remains to be demonstrated if modification of the endogenous locus, as opposed to 165 overexpression of the mutant enzyme, can result in cellular resistance to ouabain. 166 Therefore, we tested whether targeting this region using the CRISPR-Cas9 system could 167 induce such a phenotype. 168
169
We identified two highly active sgRNAs targeting SpCas9 to the exon encoding the 170 first extracellular loop (hereafter named G2 and G4) and one sgRNA targeting the 171 adjacent intron (hereafter named G3) ( Fig. 1a,b) . Starting three days post transfection the 172 cells were treated with ouabain and monitored for survival and growth. Active nucleases 173 targeting the coding sequence (G2 and G4) induced cellular resistance while cells cleaved 174 in the intron with G3 all died within 48 hours ( Fig. 1a,b ). In agreement with previous 175 reports, we have not observed any spontaneous resistance to ouabain treatment 24, 25 . As 176 ATP1A1 is essential for cell survival, these observations suggest that in frame insertions 177 and deletions were created in the first extracellular loop preventing ouabain binding 178 without crippling enzymatic activity. To assess the spectrum and frequency of targeted 179 mutations generated in these pools of cells we used the TIDE (Tracking of Indels by 180 DEcomposition) method 26 . This analysis revealed that in-frame deletions are selected for 181 over time and upon ouabain treatment and that G2 generates a much more diversified set 182 of mutations than G4, which correlates with a higher fraction of in frame deletions and 183 more robust growth ( Supplementary Fig. 1 ). It also shows that the surveyor nuclease 184 assay used to determine the frequency of small insertions and deletions (indels) 185 characteristic of imprecise DSB repair by NHEJ (hereafter, the acronym NHEJ will be 186 used to describe mutagenic repair since the precise religation of the DSBs cannot be 187 detected using this assay) saturates when samples with high levels of modification are 188 tested ( Fig. 1b) . Cloning and sequencing ATP1A1 alleles from ouabain-resistant cells 189 identified in frame deletion products resulting in disruption of the first extracellular loop 190 of the pump (Fig. 1c) . 191 192 Next, we aimed to test whether it was possible to create gain-of-function alleles by 193 HDR. Reaching a high threshold of HDR in human cells is a major challenge in the 194 genome-editing field since, at the population level, cells favor DSB repair via NHEJ over 195 HDR. Therefore, cleaving within the coding sequence of ATP1A1 would disfavor the 196 recovery of cells edited through HDR at the expense of cells mutated via NHEJ since 197 ouabain would select for both type of repair events. We took advantage of the highly 198 active sgRNA G3 that targets SpCas9 to the intron to achieve selection exclusively via 199 HDR-driven events ( Fig. 1b,d) . Two single-stranded oligos (ssODNs) were designed to 200 create ATP1A1 alleles conferring ouabain resistance by replacing both border residues of 201 the first extracellular loop with charged amino acids 25 . The ssODN donors create the 202 double replacements Q118R, N129D (RD) and Q118D, N129R (DR), destroy the 203 protospacer-adjacent motif (PAM) and include additional silent mutations to create 204 restriction sites to facilitate genotyping ( Fig. 1d) . Cas9-expressing cells were co-205 transfected with sgRNA G3 along with ssODNs and growth was monitored following 206 addition of ouabain. Cells survived and grew robustly only in the presence of the nuclease 207 and either donors. Restriction fragment length polymorphisms (RFLP) assays confirmed 208 the introduction of the desired sequence changes and their enrichment upon ouabain 209 treatment ( Fig. 1e and Supplementary Fig. 2 ). In addition, increasing the dose of 210 ouabain selected for the double mutants within the population (Supplementary Fig. 2) . 211
This was not totally unexpected since single mutations at either position confer an 212 intermediate level of resistance 25 . We speculate that it may be possible to select cells 213 having experienced longer gene conversion tracks by increasing the dose of ouabain 214 during selection. Titration of ouabain in the culture medium indicates that cells modified 215 through HDR are resistant to concentration of the drug of at least 1mM, which is more 216 than 100 fold higher than for NHEJ-induced mutations and more than 2000 fold higher 217 than what is needed to kill the cells (0.5µM). These values correspond to the level of 218 resistance observed in cells overexpressing the mutant enzymes and highlight the wide 219 range of doses that can be used for selection 25 . Thus, optimization of the drug-based 220 selection process for various cell lines is straightforward as it is not necessary to precisely 221 titrate the amount of ouabain required for selection. 222
223
These results could be reproduced using the type V CRISPR system from 224
Acidaminococcus sp. Cpf1 (AsCpf1), a single-RNA-guided (crRNA) enzyme that 225 recognizes a TTTN PAM and produces cohesive double-stranded breaks (DSBs) 27 226 ( Supplementary Fig. 2) . 227
228
In addition, this positive selection was also observed in U2OS, HEK293 and the 229 diploid hTERT-RPE1 cells ( Supplementary Fig. 2 and below). We note that, in selected 230 cells with more than two copies of ATP1A1, the fraction of in-frame indels or HDR-231 alleles can be lower than 50%. For example, in a triploid cell line, the minimal expected 232 signal for these dominant gain-of-function mutations is 33%. Thus, we identified highly 233 active CRISPR-Cas9 and CRISPR-Cpf1 RNA-guided nucleases capable of producing 234 gain-of-function alleles at the ATP1A1 locus via either NHEJ or HDR. 235 236
Co-selection strategy for enriching cells harboring CRISPR-driven gene disruption 237 events 238
To test whether selection for the above mentioned gain-of-function alleles in 239 ATP1A1 can result in co-enrichment of NHEJ-driven mutations at a second locus, we 240 built an all-in-one vector containing tandem U6-driven sgRNA expression cassettes along 241
with CBh-driven high specificity eSpCas9(1.1) 28 ( Fig. 2a,b) . Cells were transfected with 242 a vector for targeting both EMX1 and ATP1A1 and either selected with ouabain or left 243 untreated before genomic DNA was harvested. The frequencies and spectrum of indels in 244 these cell populations was determined by TIDE revealing a marked increase in gene 245 disruption reaching as high as 83% upon selection ( Fig. 2c and Supplementary Fig. 3) . 246
In these experiments, transfection of low and high doses of vector was used to simulate 247 the impact of co-selection at a broad range of gene editing frequencies. Similar results 248
were obtained when co-targeting the AAVS1 and ATP1A1 loci ( Fig. 2d and 249 Supplementary Fig. 3 ). In this experiment, the 500ng vector dose transfection was very 250 efficient and starting gene disruption levels were high at both ATP1A1 and AAVS1 and no 251 further increase was observed following ouabain treatment ( Fig. 2d) . Surveyor assays 252 performed on all samples corroborated these results (Supplementary Fig. 4 ). Despite 253 reaching almost saturating on-target disruption rates, we could not detect activity at 254 known off-target sites for both EMX1 and AAVS1 in these stably modified cell 255 populations 28, 29 ( Supplementary Fig. 4) . These data indicate that the co-selection 256 process does not negatively impact the enhanced specificity of the eSpCas9(1.1) 257 variant 28 . 258 259 Next, we took advantage of the multiplexing capacity of the CRISPR-Cpf1 system 260 to perform co-selections using all-in-one AsCpf1 expression vectors containing crRNA 261 arrays 30 . We observed improvements in gene disruption efficiency for all four previously 262 published guides, whether expressed in pairs with the ATP1A1-targeting guide or as a full 263 array co-expressing five guides simultaneously ( Fig. 2e-h and 6). As previously observed for SpCas9, the pattern of DNA repair following 266 eSpCas9(1.1) and AsCpf1 cutting at each site is nonrandom, consistent across cell lines 267 and independent of absolute efficacy 31 . AsCpf1 has been shown to be highly specific for 268 its target based on genome-wide specificity assays in human cells so only one known off-269 target site could be tested amongst the four guides used in the present study 32, 33 . While 270 we observed off-target cleavage for the DNMT1-targeting guide in transiently transfected 271 K562 cells we could not detect mutagenesis at this site in ouabain selected cells, even 272 though the on-target activity was superior ( Supplementary Fig. 7) . In contrast, in 273 HEK293, off-target activity was low but apparent ( Supplementary Fig. 7) . Thus, it 274 appears that the co-selection process does not result in overt off-target activity. 275
Collectively, these data show that CRISPR-driven gain-of-function mutations at the 276 endogenous ATP1A1 gene can be used efficiently for co-selection via NHEJ. 277 278
Robust co-selection for cells harboring CRISPR-driven HDR events 279
We then tested if selection for cells having experienced a CRISPR-driven HDR 280 event at ATP1A1 could provide a substantial enrichment for correctly targeted cells at a 281 second locus. We targeted two endogenous genes to generate N-and C-terminal fusions 282 with fluorescent proteins in order to facilitate the quantification of HDR events through 283 FACS-based analysis. To label chromatin, the HIST1H2BK locus was targeted to create a 284 C-terminal fusion of H2B with monomeric Azami-Green (mAG1) (Fig. 3a) . For both 285 wild-type (WT) and eSpCas9(1.1) the fraction of cells expressing the fusion protein 286 increased from below 1% to ~13-15% after ouabain treatment (Fig. 3b) . The absence of 287 promoter elements in the homology arms of the donor vector along with the clear 288 chromatin-linked fluorescent signal suggests that the process enriched for correctly 289 targeted cells ( Fig. 3c) . Next, we inserted the coding sequence for the green fluorescent 290 protein Clover or the red fluorescent protein mRuby2 after the second codon of the 291 LMNA gene, which encodes the lamin A and lamin C isoforms 17 (Fig. 3d) . For both 292
Clover and mRuby2 donors we detected a marked increase in signal ranging from ~5-6% 293 to ~40-50% upon ouabain selection and the cells displayed the distinct localization 294 pattern of fluorescence enriched at the nuclear periphery ( Fig. 3e and Supplementary 295 HDR rates at ATP1A1 as determined by RFLP assays (Fig. 3f) . To determine whether the 300 enrichment at the co-selected LMNA locus occurs solely for alleles that repaired the DSB 301 via HDR, or whether NHEJ-produced alleles are also enriched for, we performed out-out 302 PCR analysis on ouabain selected samples followed by TOPO cloning and sequencing 303 ( Supplementary Fig. 9 ). Sequencing of 44 non-targeted alleles revealed 7 WT sequences 304 and 37 alleles with indels at the predicted cleavage site (Supplementary Fig. 9 ). Thus, 305 NHEJ-produced alleles are also enriched for but a fraction of the cells are likely to have 306 both a targeted and a WT allele. Sequencing of the targeted alleles also indicates that the 307 integration occurred through homologous recombination. Similarly, sequencing of 308 ATP1A1 alleles revealed 10 WT, 35 NHEJ, and 39 HDR-related events out of 84 reads 309 ( Supplementary Fig. 9 ). None of the NHEJ-based deletions extended to the exon. 310
Among HDR events, directional co-conversion of SNPs from the DSB was evident (see 311 Fig. 1d ). All 39 clones had incorporated the ClaI site (mutated PAM), 30 had 312 incorporated both the ClaI and the BmgBI sites, and 17 had integrated the 3 RFLP sites. 313
As observed for H2BK, co-selection was efficient for both WT SpCas9 and eSpCas9(1.1) 314 and co-selection using AsCpf1 was also achieved in this system (Supplementary Fig. 8) . 315
Stimulation of targeted integration of transgene cassettes was also successful at two 316 distinct loci, namely AAVS1 and HPRT1 (Supplementary Fig. 8 ). Taken together, these 317 data demonstrate that co-selection for ouabain resistant cells markedly improved the 318 outcome of HDR-driven gene editing experiments, irrespective of the target locus. 319 320
Enabling affinity purification of endogenous protein complexes from co-selected 321 polyclonal cell populations 322
Having demonstrated that co-selection could generate highly modified cell 323 populations we tested whether functional assays could be performed directly in these 324 pools, thus bypassing single-cell cloning steps. We used tools that we previously 325 developed to build an interface between genome editing and proteomics in order to 326 isolate native protein complexes produced from their natural genomic contexts, an 327 approach that led to the identification of novel interactions in chromatin modifying and 328 DNA repair complexes 34 . Using co-selection, we tagged the enhancer of polycomb 329 homolog 1 (EPC1) and the E1A binding protein p400 (EP400), two essential subunits of 330 the NuA4/TIP60 acetyltransferase complex that promote homologous recombination by 331 regulating 53BP1-dependent repair 35 (Fig. 4a,b) . Out-out PCR-based assays and western 332 blotting confirmed the correct integration of the affinity tag at both loci and the 333 enrichment of tagged cells upon ouabain treatment (Fig. 4c,d) . Nuclear extracts were 334 prepared from the cell pools as well as from WT K562 cells (Mock), and subjected to 335 tandem affinity purification (TAP). EPC1 and EP400 complex subunits separated by 336 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) could be unambiguously 337 identified on silver stained gels and are virtually identical to the patterns obtained from 338 clonal cell lines 34 (Fig. 4e) . Successful tagging via co-selection was also achieved in 339 HEK293 cells (Supplementary Fig. 10) . These results represent an additional step 340 toward high-throughput genome-scale purification of native endogenous protein 341 complexes in human cells. 342 343
Efficient enrichment of gene-edited human hematopoietic stem and progenitor cells 344 (HSPCs) 345
To explore the potential for clinical translation of our method we tested the ouabain 346 selection strategy during ex vivo expansion of cord blood-derived human hematopoietic 347 stem and progenitor cells (HSPCs). Genome editing in HSPCs by homologous 348 recombination remains challenging but offers the possibility to treat several genetic 349 diseases 36 . We used previously developed tools to introduce a mutation in the beta-globin 350 (HBB) gene causing sickle cell disease (SCD) 37-39 ( Fig. 5a) various donors and using different ssODNs (Fig. 5b,c and Supplementary Fig. 11) . 358
These results support the notion that the process could be adapted for use in preclinical 359 studies. Critically, these data demonstrate that the procedure is applicable to diploid 360 primary cells. 361
362

DISCUSSION 363
Here we demonstrate that the creation of gain-of-function alleles at the ATP1A1 364 locus with CRISPR-Cas9 and Cpf1 can be robustly selected for using a highly potent 365 therapeutic small molecule in order to enrich for custom modifications at another 366 unlinked locus of interest, substantially increasing the recovery of engineered cells. A 367 defining aspect of our system is that the co-selection process can be initiated through 368 NHEJ-or HDR-driven events independently. One only has to switch between two 369 validated sgRNAs targeting juxtaposed regions of ATP1A1 and include an ssODN in the 370 transfection reaction to co-select for HDR-instead of NHEJ-driven events. Perhaps more 371 importantly, we show that the co-selection strategy markedly enriches for cells modified 372 via homologous recombination, a clear limitation in the field. This was demonstrated at 373 endogenous loci for five different types of HDR-driven genome editing events; (i) RFLP 374 knock-in, (ii) gene trapping, (iii) targeted integration of an autonomous expression 375 cassette, (iv) protein tagging with fluorescent markers, and (v) epitope tagging. As shown 376
in the examples above, the extent of enrichment for HDR-edited cells varied at different 377 sites and according to the type of modification created at the locus of interest. Of 378 particular importance, robust selection is achieved without the use of exogenous DNA 379 markers making it potentially compatible with therapeutic applications. Further work and 380 optimization will reveal if the gene editing and selection process is compatible with a 381 variety of primary cell types. The well-defined mechanism of action of ouabain acting on 382 a nonsignaling ion pump independently of proliferation is another distinct advantage of 383 the method. Ouabain treatment kills cells within 48 hours of exposure and targeted cells 384 display no apparent growth delay resulting from the selection process. Accordingly, the 385 point mutations engineered to confer ouabain resistance are naturally occurring in mice, 386 rats, monarch butterflies, leaf beetles, and some toads 41 . In addition, these mutant 387 enzymes function normally, as shown by 86 Rb + uptake and ATP hydrolysis assays 25 . The 388 turnover of ATP1A1 at the plasma membrane appears to be rapid since ouabain can be 389 added to the culture medium as early as 15 hours post transfection of the CRISPR 390 components, even if they are encoded on plasmids (data not shown). Although not 391 formally tested in this study, the process should be compatible with any engineered 392 nuclease platforms and any cell type since ATP1A1 is ubiquitously expressed. 393
394
These results corroborate earlier observations that cells proficient at completing one 395 genomic manipulation have an increased probability of completing a second, independent 396 genomic manipulation, provided they are mediated by sufficiently similar mechanisms of 397 DNA repair 18, 19, 21 . Powerful co-selection schemes such as the one described in this study 398 may offer the opportunity to efficiently correct a mutation "at distance" and avoid 399 complications caused by on-target NHEJ-based mutagenesis of the non-corrected allele. Technically, it is interesting to note that this residue is encoded next to an intron-exon 410 boundary and could be targeted in a similar fashion as ATP1A1 to favor enrichment of 411 cells edited via HDR (Supplementary Fig. 11) . 412
413
Remarkably, robust co-selection for NHEJ-based on-target mutagenesis does not 414 yield overt off-target activity when enhanced fidelity variants of SpCas9 are used. In fact, 415
we did not detect mutagenesis at sites where WT SpCas9 is known to cleave. It also 416 appears that the co-enrichment of indels at off-target sites is limited compared to the one 417 observed at on-target loci, as shown for AsCpf1. As the amount of CRISPR components 418 can be titrated to improve the ratio of on-target to off-target mutation rates, an unexpected 419 advantage of the co-selection strategy may be to achieve this balance without reducing 420 the final on-target efficacy. This will hold true if transfecting lower amounts of plasmids 421 results in lower levels of the nuclease on a per-cell basis. Translocations between 422 ATP1A1 and the locus of interest will occur at some frequency and there is a slight 423 probability that this event will be found in the selected population. 424
425
In conclusion, we established a simple method that can be broadly applied to 426 increase the frequency of genome editing events in human cells. It is easy to implement 427 in any laboratory, as it only requires a universal set of CRISPR reagents and an 428 inexpensive commercially available drug. Furthermore, by design, it was built to be 429 compatible with any nuclease platform and most other strategies developed to facilitate 430 the use of this powerful technology. HDR can be found in Supplementary Table 1 . Ouabain octahydrate (Sigma) was 444 dissolved at 50 mg/ml in hot water and stored at -20 °C. Working dilutions were prepared 445 in water and added directly to the culture medium. 446
447
CRISPR-Cas9 and Cpf1 reagents 448
The CAG-driven human codon optimized Cas9 nuclease vectors hCas9 was a gift from 449
George Church (Addgene plasmid # 41815) 43 Table  457 2. The DNA sequence for the guides were modified at position 1 to encode a 'G' due to 458 the transcription initiation requirement of the human U6 promoter when required. The 459 reagents targeting the LMNA gene have been described 17 . To test the high specificity Supplementary Table 3 . 469
The dual AsCpf1 and U6-driven crRNA array expression vector was built in pY036 (a 470 gift from Feng Zhang) as described 30 . Desalted ssODNs ( Supplementary Table 4 ) were 471 synthesized as ultramers (IDT) at 4 nmole scale. All plasmid donor sequences contain 472 short homology arms (<1 kb) and have been modified in order to prevent their cleavage 473 by Cas9 as described 34 . The only exception to this rule was for the targeting of Clover to 474 the LMNA locus using AsCpf1. eSpCas9(1.1) and AsCpf1 expression vectors targeting 475 ATP1A1 have been deposited to Addgene (Supplementary Fig. 13) . were amplified by 30 cycles of PCR using the primers described in Supplementary Table  481 5. Assays were performed with the Surveyor mutation detection kit (Transgenomics) as 482 described 44 . Samples were separated on 10% PAGE gels in TBE buffer. For RFLP 483 assays, the PCR products were purified and digested with the corresponding enzyme and 484 resolved by 10% PAGE. Gels were imaged using a ChemiDoc MP (Bio-Rad) system and 485 quantifications were performed using the Image lab software (Bio-Rad). TIDE analysis 486 was performed using a significance cutoff value for decomposition of p<0.005 26 . To 487 analyze targeted integration via out-out PCR, genomic DNA extracted with QuickExtract 488 DNA extraction solution was subjected to 30 cycles of PCR for LMNA and 35 cycles for 489 EPC1 and EP400 using the primers described in Supplementary Table 6 . Amplicons were 490 loaded on 1% agarose gels in TAE buffer. 491 492
Flow cytometry 493
The frequency of EGFP, mAG1, Clover, and mRuby2 expressing cells was assessed 494 using a BD LSR II flow cytometer and gated for viable cells using 7-aminoactinomycin 495 D (7-AAD). 496
TAP 497
Nuclear extracts and purifications were performed from ~5E8 cells as described 34 . For crRNA:tracrRNA complex formation, the two RNA oligos were mixed in equimolar 532 concentrations, heated at 95°C for 5 minutes and transferred to ice immediately. 533
Immediately prior to nucleofection, 50pmol of Cas9 protein (Integrated DNA 534
Technologies) was incubated with 125pmol of crRNA:tracrRNA complexes at RT for 10 535 minutes to form the RNP complexes along with 100pmole of each ssODNs. Note that the 536 ATP1A1 G3 guide was not active in the Alt-R CRISPR system (Integrated DNA 537 Technologies), thus we used the ATP1A1 G4 guide to make RNPs. This guide generates 538 low levels of ouabain resistance via NHEJ in HSPCs and robust cell growth is only 539 observed in the presence of ssODN donors ( Supplementary Table 4 ). 
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